Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06350955
Status:
RECRUITING
Last Update Posted:
2024-04-08
First Post:
2024-03-28
Brief Title:
IV Iron-induced Hypophosphatemia After RYGB
Sponsor:
Lucie Favre
Organization:
Centre Hospitalier Universitaire Vaudois
Study Overview
Official Title:
Intravenous Iron-induced Hypophosphatemia in Patients With Roux-en-Y Gastric Bypass a Single-blind Randomized Clinical Trial Comparing Iron Isomaltoside Monofer and Ferric Carboxymaltose Ferinject
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IVORY
Brief Summary:
The primary objective of the study is to compare the incidence of hypophosphatemia in RYGB patients treated with intravenous IV single dose of iron isomaltoside Monofer or ferric carboxymaltose Ferinject
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None